Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pfizer Signs Pact With Washington University

February 4, 2008 | A version of this story appeared in Volume 86, Issue 5

Pfizer has formed a five-year, $25 million research collaboration with Washington University, St. Louis, in the field of immunoinflammatory disorders. University officials say the pact is a departure from traditional academic-industry deals in which companies give universities wide berth to choose research projects. In this case, they say, university and Pfizer scientists will jointly propose, design, and carry out the research projects in order to better capture usable innovations. "We believe it will serve as a new paradigm for other academic-industry collaborations," says Washington University Chancellor Mark Wrighton.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.